154 related articles for article (PubMed ID: 38713345)
1. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D
Shintani T; Higaki M; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38713345
[TBL] [Abstract][Full Text] [Related]
2. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
3. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1).
Higaki M; Shintani T; Hamada A; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):222-233. PubMed ID: 32185608
[TBL] [Abstract][Full Text] [Related]
4. Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells.
Shintani T; Higaki M; Okamoto T
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072393
[TBL] [Abstract][Full Text] [Related]
5. 1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.
Rosli SN; Shintani T; Toratani S; Usui E; Okamoto T
In Vitro Cell Dev Biol Anim; 2014 Oct; 50(9):802-6. PubMed ID: 24938357
[TBL] [Abstract][Full Text] [Related]
6. 1α,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-κB pathway.
Rosli SN; Shintani T; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2013 Jul; 136():98-101. PubMed ID: 23104116
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis.
Begum S; Zhang Y; Shintani T; Toratani S; Sato JD; Okamoto T
Oncol Rep; 2007 Mar; 17(3):591-6. PubMed ID: 17273738
[TBL] [Abstract][Full Text] [Related]
8. Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas.
Shintani T; Rosli SNZ; Takatsu F; Choon YF; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2016 Nov; 164():79-84. PubMed ID: 26444325
[TBL] [Abstract][Full Text] [Related]
9. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors.
Wu DQ; Kan MK; Sato GH; Okamoto T; Sato JD
J Biol Chem; 1991 Sep; 266(25):16778-85. PubMed ID: 1885605
[TBL] [Abstract][Full Text] [Related]
10. Purification of heparin-binding protein HBp17 and identification of HBp17 heparin binding site.
Wang XC; Chen JH; Crab JW; Sato JD
Biochem Mol Biol Int; 1998 Sep; 46(1):81-7. PubMed ID: 9784842
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional effects of heparin-binding protein HBp17 on DNA synthesis in cells.
Chen JH; Wang XC; Sato JD
Cell Biol Int; 2001; 25(6):567-70. PubMed ID: 11407864
[TBL] [Abstract][Full Text] [Related]
12. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
14. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing.
Tassi E; McDonnell K; Gibby KA; Tilan JU; Kim SE; Kodack DP; Schmidt MO; Sharif GM; Wilcox CS; Welch WJ; Gallicano GI; Johnson MD; Riegel AT; Wellstein A
Am J Pathol; 2011 Nov; 179(5):2220-32. PubMed ID: 21945411
[TBL] [Abstract][Full Text] [Related]
15. Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)
Olszewska AM; Nowak JI; Myszczynski K; Słominski A; Żmijewski MA
Mol Cell Endocrinol; 2024 Mar; 582():112124. PubMed ID: 38123121
[TBL] [Abstract][Full Text] [Related]
16. Temporal and spatial expression of fgfbp genes in zebrafish.
Li Y; Sun S; Ding Z; Yang C; Zhang G; Jiang Q; Zou Y
Gene; 2018 Jun; 659():128-136. PubMed ID: 29551495
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71].
Hatakeyama S; Yoshino M; Eto K; Takahashi K; Ishihara J; Ono Y; Saito H; Kubodera N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):25-8. PubMed ID: 20304058
[TBL] [Abstract][Full Text] [Related]
18. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
Ratnam AV; Bikle DD; Su MJ; Pillai S
J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
[TBL] [Abstract][Full Text] [Related]
19. Different impact of vitamin D on mitochondrial activity and morphology in normal and malignant keratinocytes, the role of genomic pathway.
Olszewska AM; Nowak JI; Król O; Flis D; Żmijewski MA
Free Radic Biol Med; 2024 Jan; 210():286-303. PubMed ID: 38040270
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
